PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-3

  1. 3,006 Posts.
    lightbulb Created with Sketch. 504
    Hopefully, this will stop the SP rot!

    Onwards and Upwards!
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.